The Trump administration has brokered agreements with six major hospital systems to end childhood gender transition procedures.
| PULSE POINTS |
❓ WHAT HAPPENED: The Trump administration, through the Department of Justice (DOJ), has forced six major hospital systems, including New York University (NYU) Langone Hospitals and the University of Pittsburgh Medical Center, to agree to cease providing puberty blockers, cross-sex hormones, and surgeries to minors. These agreements also include financial settlements, such as NYU paying $8.5 million and UPMC $950,000, to resolve investigations into their potential violations of federal laws. 📺 DETAIL: The DOJ’s investigation, launched on President Donald J. Trump’s orders in 2025, examines potential violations of federal health laws, including the False Claims Act and the Food, Drug, and Cosmetic Act. Allegations include misuse of diagnosis codes to obtain payments for gender transition procedures. While some hospitals had already ceased such treatments due to state laws or prior pressure, the DOJ agreements formalize these commitments and include provisions for restorative care for people harmed by prior treatments. 💬 KEY QUOTE: “Hospitals that target children in these practices and then fraudulently obtain payment for the procedures will be held to account.” – Attorney General Todd Blanche 🎯 IMPACT: These agreements mark a significant step in the Trump administration’s effort to curtail childhood gender transitions nationwide, with ongoing investigations signaling further actions against other providers. 📺 FLASHBACK: Since May, similar agreements have been reached with Mount Sinai Health System, Texas Children’s Hospital, Cleveland Clinic, and Connecticut Children’s Hospital. Notably, Texas Children’s Hospital had already ceased such treatments prior to its settlement, which also included a $10 million payment and the establishment of a restorative care clinic. 🎯 CAVEAT: The hospitals involved generally deny wrongdoing, with the settlements resolving allegations rather than proven liabilities. |
Join Pulse+ to comment below, and receive exclusive e-mail analyses.
show less
